Karen S. Rommelfanger

KR

Director, Neuroethics Program
Assistant Professor, Departments of Neurology and Psychiatry and Behavioral Sciences
(404) 727-1150
krommel@emory.edu

CV  Personal Page

Karen Rommelfanger is the Neuroethics Program Director at the Center for Ethics and an Assistant Professor in the Department of Neurology and the Department of Psychiatry and Behavioral Sciences. Dr. Rommelfanger received her PhD in Neuroscience from Emory University, her research focused on movement disorders. Her current research explores the nature and utility of placebo using Psychogenic Movement Disorders as a therapeutic model. Her broader research cannon explores how evolving neuroscience and neurotechnologies challenge societal definitions of disease and medicine. She is also the Neuroscience Editor-in-Residence for the American Journal of Bioethics Neuroscience.    Dr. Rommelfanger was recently appointed to the NIH BRAIN Initiative Neuroethics Workgroup.

Dr. Rommelfanger has been a neuroscience researcher for over 10 years and her work has been published in high-impact peer-reviewed journals such as the Proceedings of the National Academy of Sciences, and the Journal of Neuroscience; her research on Parkinson Disease has been featured in the popular media including Scientific American. She has presented her work at both international and national conferences and has worked in prestigious laboratories in the U.S. and Japan using a broad array of neurotechnologies from brain imaging and behavioral techniques to electrophysiological recording of individual brain cells.

She regularly gives Neuroethics talks in both universities and for general audiences; her neuroethics work has been published in top peer-reviewed neuroethics journals and Nature Reviews Neurology and Neuron. She maintains and writes for The Neuroethics Blog at Emory University. Dr. Rommelfanger's public scholarship has been featured in The Huffington Post, The Chronicle for Higher Education, and Nature blogs and she has been quoted in popular media outlest such as The New York Times and USA Today. She also founded NEW (NeuroEthicsWomen) Leaders, an organization that aims to cultivate professional development and scholarly networks for women and under-represented groups in neuroethics. She is a founding member of the Atlanta Neuroethics Consortium. Dr. Rommelfanger believes that neuroethics training gives neuroscientists a creative edge and that neuroethics discussions are critical for academics and general audiences alike in order to ensure maximal benefit of neuroscience discoveries for society.   

Areas of Expertise:

Brain Machine Interface
Cognitive Enhancement
Psychogenic Disorders
Placebo
Neuroscience
Neuroethics
Neuroscience communication

Speaking Engagements